This research certifies that down-regulation of Robo2 can facilitate the EMT and proliferation, and constrain the apoptosis of HCC cells by regulating YB-1, which provided a basis for the pathogenesis of HCC and a potential new target for the clinical therapy of HCC. This evidence concerns the gene ROBO2 and hepatocellular carcinoma.